News

Partner news

8 April 2019

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story

Partner news

1 April 2019

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story

Partner news

28 February 2019

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story

Partner news

21 February 2019

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

Read full story

Partner news

20 February 2019

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

Read full story

Partner news

14 February 2019

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Read full story

Partner news

13 February 2019

New strategic partners join £9.5 million dementia drug discovery collaboration

Read full story

Partner news

24 January 2019

Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth

Read full story

Partner news

23 January 2019

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story

Partner news

4 January 2019

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Read full story

Partner news

3 January 2019

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

Read full story

Partner news

12 December 2018

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

Read full story

Partner news

11 December 2018

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

Read full story

Partner news

29 November 2018

ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Read full story

Partner news

5 November 2018

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story